Investment Management of Virginia’s iShares Biotechnology ETF IBB Stock Holding History

Investment Management of Virginia’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$322K	Hold	2,490	–	–	0.06%	161
2022 Q4	$327K	Hold	2,490	–	–	0.06%	161
2022 Q3	$291K	Hold	2,490	–	–	0.06%	159
2022 Q2	$293K	Buy	+2,490	New	+$296K	0.06%	160
2022 Q1	–	Sell	-3,500	Closed	-$534K	–	183
2021 Q4	$534K	Hold	3,500	–	–	0.09%	147
2021 Q3	$566K	Hold	3,500	–	–	0.11%	130
2021 Q2	$573K	Buy	+3,500	New	+$539K	0.11%	132
2020 Q4	–	Sell	-3,500	Closed	-$474K	–	152
2020 Q3	$474K	Hold	3,500	–	–	0.12%	123
2020 Q2	$478K	Hold	3,500	–	–	0.12%	119
2020 Q1	$377K	Hold	3,500	–	–	0.11%	124
2019 Q4	$422K	Hold	3,500	–	–	0.1%	121
2019 Q3	$348K	Hold	3,500	–	–	0.09%	125
2019 Q2	$382K	Sell	3,500 -42,358	-92%	-$4.51M	0.09%	131
2019 Q1	$5.13M	Buy	45,858 +20,844	+83%	+$2.29M	0.61%	55
2018 Q4	$2.41M	Sell	25,014 -8,756	-26%	-$929K	0.63%	52
2018 Q3	$4.12M	Hold	33,770	–	–	0.87%	33
2018 Q2	$3.71M	Buy	+33,770	New	+$3.61M	0.82%	37

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Investment Management of Virginia's IBB Position: Q1 2023 in Review

Investment Management of Virginia held its iShares Biotechnology ETF (IBB) position steady in Q1 2023 at 2,490 shares worth $322K. The position accounts for 0.06% of the portfolio, ranked #161.

Investment Management of Virginia first reported a position in IBB in Q2 2018 and has held it in 17 quarters since. The position peaked at $5.13M in Q1 2019. 867 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

Investment Management of Virginia held 2,490 shares of iShares Biotechnology ETF worth $322K as of Q1 2023.
Investment Management of Virginia left its iShares Biotechnology ETF share count unchanged in Q1 2023.
iShares Biotechnology ETF made up 0.06% of Investment Management of Virginia's portfolio in Q1 2023, its #161 holding.
Investment Management of Virginia first reported a position in iShares Biotechnology ETF in Q2 2018 and has held it in 17 quarters since.
Investment Management of Virginia's iShares Biotechnology ETF position peaked at $5.13M in Q1 2019.
867 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on Investment Management of Virginia's 13F filing for Q1 2023, filed 26 Apr 2023.